Skip to main content

Table 2 Univariate and multivariate Cox regression analysis of factors associated with OS for the main training cohort

From: A prognostic model using the neutrophil-albumin ratio and PG-SGA to predict overall survival in advanced palliative lung cancer

Variable

Univariate

P value

Multivariate

P value

HR (95% CI)

HR (95% CI)

Significant factors

 Age ≥ 60 years (vs. < 60 years)

1.383 (1.023–1.871)

0.035

1.215 (0.885–1.669)

0.229

 KPS < 70 (vs. ≥ 70)

2.046 (1.501–2.789)

 < 0.001

0.750 (0.524–1.074)

0.116

 Stage IV (vs. IIIB)

1.784 (1.131–2.814)

0.013

1.794 (1.124–2.863)

0.014

 Loss of appetite

2.123 (1.586–2.842)

 < 0.001

1.192 (0.861–1.651)

0.290

 Cancer pain

1.929 (1.268–2.932)

0.002

1.354 (0.869–2.108)

0.180

 Treatment method, supportive care (vs. others)

5.551 (3.939–7.709)

 < 0.001

3.457 (2.383–5.016)

 < 0.001

 NLR, > 6.8 (vs. ≤ 6.8)

2.619 (1.922–3.569)

 < 0.001

1.082 (0.713–1.642)

0.711

 NAR, > 0.15 (vs. ≤ 0.15)

2.831 (2.102–3.813)

 < 0.001

1.674 (1.108–2.527)

0.014

 PG-SGA score, > 12 (vs. ≤ 12)

3.348 (2.481–4.519)

 < 0.001

2.396 (1.665–3.446)

 < 0.001

Nonsignificant factors

 Sex, female (vs. male)

1.299 (0.931–1.813)

0.123

  

 Histology, small-cell lung cancer (vs. other)

1.329 (0.903–1.956)

0.150

  

 Diarrhoea

1.625 (0.902–2.928)

0.106

  

 Nausea

1.015 (0.700–1.472)

0.938

  

 Vomiting

1.223 (0.823–1.818)

0.319

  
  1. Abbreviations: CI Confidence Interval, HR Hazard Ratio, KPS Karnofsky Performance Status, NLR Neutrophil-to-lymphocyte Ratio, NAR Neutrophil-albumin Ratio, PG-SGA Patient-Generated Subjective Global Assessment